Medication info
Alentop Plus D Tablets

Alentop Plus D Tablets

Prescription medicationTabletOral
Ingredient · strength
Sodium Alendronate Hydrate›91.37mg / 1 tabletCholecalciferol Concentrate Powder›53.33mg / 1 tablet
Manufacturer / importer
Hanol Bio Pharma Co., Ltd.
Appearance
White to grayish rectangular tablet
Packaging
4 tablets/PTP
Approval status
Active

MFDS item code 201308588 · Approved 2013.07.31 · Insurance code 655604540

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults · Children
Adult dose
Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with plenty of water, at least 30 minutes before eating, drinking, or taking any other medication (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. For patients at low risk of fracture, discontinuing treatment after 3~5 years should be considered. Patients who discontinue treatment should be reassessed regularly for fracture risk. Other beverages or food, including mineral water and barley tea, as well as medications, may reduce the absorption of alendronate (see “Drug Interactions”). Eating within 30 minutes after taking this medicine or at the same time may reduce the absorption of alendronate in the body and decrease its effect. This medicine should be taken as soon as you get up in the morning and swallowed with plenty of water (170∼230 mL) to deliver the medicine rapidly to the stomach and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after your first food intake. Do not take this medicine at bedtime or before getting up. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients with inadequate dietary intake of calcium and vitamin D should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, nursing home residents, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Taken once weekly, one tablet of this medicine provides one week's supply of daily vitamin D at 400 IU or 800 IU. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, they should take 1 tablet the next morning, resume taking it on the regularly scheduled day, and then continue taking it regularly once weekly. However, do not take 2 tablets on the same day. Use in older adults (65 years and older): No dosage adjustment is necessary. Use in patients with renal impairment: No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance of 35∼60 mL/min). However, use of this medicine is not recommended in patients with severe renal impairment (creatinine clearance below 35 mL/min), as there is insufficient clinical experience.
Child dose
Children and adolescents (under 18 years of age): Safety and efficacy have not been established in children and adolescents.

Ingredients

Manufacturer
Hanol Bio Pharma Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

This medicine is used for the treatment of osteoporosis in postmenopausal women and men.

How to take

Adult dose

Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with plenty of water, at least 30 minutes before eating, drinking, or taking any other medication (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. For patients at low risk of fracture, discontinuing treatment after 3~5 years should be considered. Patients who discontinue treatment should be reassessed regularly for fracture risk. Other beverages or food, including mineral water and barley tea, as well as medications, may reduce the absorption of alendronate (see “Drug Interactions”). Eating within 30 minutes after taking this medicine or at the same time may reduce the absorption of alendronate in the body and decrease its effect. This medicine should be taken as soon as you get up in the morning and swallowed with plenty of water (170∼230 mL) to deliver the medicine rapidly to the stomach and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after your first food intake. Do not take this medicine at bedtime or before getting up. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients with inadequate dietary intake of calcium and vitamin D should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, nursing home residents, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Taken once weekly, one tablet of this medicine provides one week's supply of daily vitamin D at 400 IU or 800 IU. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, they should take 1 tablet the next morning, resume taking it on the regularly scheduled day, and then continue taking it regularly once weekly. However, do not take 2 tablets on the same day. Use in older adults (65 years and older): No dosage adjustment is necessary. Use in patients with renal impairment: No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance of 35∼60 mL/min). However, use of this medicine is not recommended in patients with severe renal impairment (creatinine clearance below 35 mL/min), as there is insufficient clinical experience.

Child dose

Children and adolescents (under 18 years of age): Safety and efficacy have not been established in children and adolescents.

Precautions

This medication may irritate the upper gastrointestinal mucosa, potentially leading to adverse esophageal reactions such as esophagitis, esophageal ulcers, and esophageal erosion. If symptoms such as difficulty swallowing, pain while swallowing, pain behind the breastbone, or heartburn occur during treatment, discontinue use immediately and consult a doctor. Always take this medication with a sufficient amount of water, and do not lie down for at least 30 minutes after taking it. Patients with esophageal diseases, gastritis, duodenitis, or ulcers should exercise particular caution. This medication is not to be administered to patients with esophageal stricture or achalasia, patients who cannot sit or stand upright for more than 30 minutes, patients who have hypersensitivity to any component of the drug, or patients with hypocalcemia. Patients with genetic lactose intolerance should also exercise caution. This medication may cause side effects such as gastrointestinal disturbances, musculoskeletal pain, headache, dizziness, and taste disturbances. Particularly, if there is severe pain in bones, joints, or muscles, consult a doctor. Taking this medication with calcium supplements, antacids, aspirin, or non-steroidal anti-inflammatory drugs may increase the risk of upper gastrointestinal adverse reactions, so it is advised to space out the dosing. During pregnancy, careful consideration of potential effects on the fetus is necessary for administration, and caution is also required while breastfeeding. It is not to be used in children. It is not recommended for patients with severely impaired renal function. Upon taking, it should be taken in the morning on an empty stomach with plenty of water, and lying down for at least 30 minutes afterward is prohibited. In case of overdose, do not induce vomiting and visit a medical facility immediately. This medication should be stored out of reach of children and should not be transferred to other containers.

Side effects

esophagitis, esophageal ulcer, esophageal erosion, esophageal stricture, esophageal perforation, bleeding, dysphagia, odynophagia, retrosternal pain, heartburn, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid reflux, vomiting, abdominal distension, gastritis, musculoskeletal (bone, muscle, or joint) pain, muscle cramps, headache, dizziness, altered taste, rash, erythema, anastomotic ulcer, urticaria, vascular edema, hypersensitivity reaction, myalgia, fatigue, asthenia, fever, symptoms of hypocalcemia, peripheral edema, oropharyngeal ulcer, gastric ulcer, duodenal ulcer, localized jawbone necrosis, joint swelling, low-energy fractures of the femoral neck and other bones, itching, hair loss, Stevens-Johnson syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external auditory canal, pharyngotonsillitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, it should be protected from direct sunlight and stored at room temperature between 1°C and 30°C. This will help maintain the efficacy of the medication for a longer period.

Appearance and packaging

Appearance

White to grayish rectangular tablet

Package unit

4 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.